Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease

Date
2015
Author
Yavuzer, Hakan
Gelisgen, Remise
Irmak, Hulya
DERICI, Himmet
Uzun, Hafize
Altunoglu, Esma
GUNTAS, Gulcan
Erdenen, Fusun
AKKAYA, Esen
TOPAC, Ibrahim
Metadata
Show full item record
Abstract
BackgroundThe aim of the present study was to determine the systemic levels of oxidative stress markers, such as ischemia-modified albumin (IMA), advanced oxidation protein products (AOPP), ferric reducing antioxidant power (FRAP) and the prooxidant-antioxidant balance (PAB), to clarify protein redox homeostasis in patients with Alzheimer's disease, and to compare them with mentally healthy persons of the same age.
URI
http://hdl.handle.net/20.500.12627/50870
https://doi.org/10.1111/ggi.12361
Collections